Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021

BACKGROUND: Novel oral poliovirus vaccine type 2 (nOPV2) was used to control an outbreak of type 2 circulating vaccine derived poliovirus (cVDPV2) in Tajikistan, in 2021. We measured seroconversion and seroprevalence of type 2 polio antibodies in children who were reported to have received two doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzoev, Azamdzhon, Macklin, Grace R, Zhang, Yiting, Mainou, Bernardo A, Sadykova, Umeda, Olsavszky, Victor Stefan, Huseynov, Shahin, Ruziev, Murodali, Saidzoda, Faizali, Bobokhonova, Mahtob, Mach, Ondrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681660/
https://www.ncbi.nlm.nih.gov/pubmed/36400086
http://dx.doi.org/10.1016/S2214-109X(22)00412-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681660/
https://www.ncbi.nlm.nih.gov/pubmed/36400086
http://dx.doi.org/10.1016/S2214-109X(22)00412-0

Ejemplares similares